Deep learning

MRSA
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Artificial intelligence (AI) #Deep learning #Massachusetts Institute of Technology

AI helps find first new antibiotic in 60 years

Massachusetts Institute of Technology (MIT) researchers have used deep learning to identify a new class of antibiotic candidates that can kill methicillin-resistant Staphylococcus aureus (MRSA). The study represents more good news in the battle against antimicrobial resistance, as researchers from Harvard University and Roche also recently announced… Read More

#News #Trending News

#Clinical trials #Deep learning #Immunotherapy #Oncology #Start-ups

New podcast: Drug discovery success stories

This is the latest episode of the free DDW narrated podcast, “Drug discovery success stories”, which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Global pharma start-up success stories”, and “Excitement at rectal… Read More

#News

Science and research of the universe; quantum science
#Collaboration #Deep learning #Deep tech #Life sciences #Quantum computing #Research

Start-up accelerator to unlock potential in quantum science 

BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating life science research, has launched a new deep tech accelerator start-up programme, the Deep Tech Lab – Quantum, to propel emergent and disruptive quantum science and biotechnology solutions toward the marketplace.   Deep tech and quantum science have… Read More

#News

Immunofluorescence
#AI #Deep learning #Immunofluorescence #Spatial biology

New tool unlocks immunofluorescence data for drug discovery

A new spatial biology platform using deep learning could establish new levels of accuracy, speed, and generalisability in multiplex immunofluorescence (mIF) analysis. While mIF is a powerful technology for cancer research, current tools for mIF image analysis are time-consuming, manual, and not robust enough to generalise across different platforms, markers… Read More

#News

#AI #Deep learning #Drug discovery #Investment #Machine learning

€30 million raised to advance AI enabled drug discovery pipeline 

Aqemia has raised €30 million in a Series A funding round to further support its mission to massively scale drug discovery through a first-in-class technological platform combining quantum-inspired physics and machine learning.  The financing was led by Eurazeo and Bpifrance through its Large Venture fund, with the… Read More

#Business & Investment #News

#Clinical trials #Deep learning #Start-ups

Global pharma start-up success stories

Listen to this article on the DDW Podcast: From AI to 3D deep-learning research to biologics, Lu Rahman selects some interesting global start-ups pushing the boundaries in drug discovery. Owkin French-American startup, Owkin is focussed on using artificial intelligence (AI) to discover and develop better treatments for… Read More

#Exclusive Content #Start-up Zone

#AI / data analytics / healthtech / informatics #Deep learning #Drug discovery #Pharmaceutical

Opportunities and challenges for AI in drug discovery

By Naheed Kurji, Co-founder and Executive of the Alliance for Artificial Intelligence in Healthcare (AAIH), CEO of Cyclica; and Andreas Windemuth, Ph.D, Chief Science Officer of Cyclica Over the past decade, a new industry has arisen that seeks to apply artificial intelligence (AI), or more aptly machine learning (ML) technologies,… Read More

#Editor's Choice #Exclusive Content #Intelligence #News #Trends & Analysis